At OSN New York, Reay H. Brown, MD, shares how he used phacoemulsication to treat three different cases of patients with angle-closure glaucoma.
Uncategorized
Uncategorized
BioTime, Inc. to Host Conference Call to Update Investors on Recent Accomplishments and Corporate Objectives for 2016
ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE MKT:BTX) today announced that it will host a conference call on Thursday, March 31, to update investors on the Company’s recent accomplishments and objectives for the remainder of 2016. Among the highlights of the call will be an update on the clinical trials currently underway for Renevia® for lipoatrophy, and OpRegen® for dry age-related macular degeneration. In addition, management will discuss recent developments for its other clinical s
IUPUI researchers use stem cells to identify cellular processes related to glaucoma
Using stem cells derived from human skin cells, researchers led by Jason Meyer, assistant professor of biology, along with graduate student Sarah Ohlemacher of the School of Science at Indiana…
Before retinal cells die, they regenerate, Penn vet blindness study finds
Until relatively recently, the dogma in neuroscience was that neurons, including the eye’s photoreceptor cells, rods and cones, do not regenerate.
Stanford scientists develop new technique for imaging cells and tissues under the skin
A team of Stanford Bio-X scientists developed the first technique for viewing cells and tissues in 3 dimensions under the skin — the work could improve diagnosis and treatment for some forms of…
Inherited Retinal Degenerative Disease Registry
Status: Recruiting,
Condition Summary: Eye Diseases Hereditary; Retinal Disease; Achromatopsia; Bardet-Biedl Syndrome; Bassen-Kornzweig Syndrome; Batten Disease; Best Disease; Choroidal Dystrophy; Choroideremia; Cone Dystrophy; Cone-Rod Dystrophy; Con…